← Leaderboards
Stephen Dewhurst
University Of Rochester
$37,837,871
Attributed
$50,357,791
Total exposure
34
Grants
21
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.6M · FY2005–24$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$64,910,711 · 35
By mechanism
P30$26,914,476 · 8
UM1$7,244,071 · 1
K12$6,940,710 · 1
R01$5,636,869 · 4
R21$4,097,451 · 10
OT2$4,000,000 · 1
Top collaborators
- Richard L Doolittle5 shared
- Gerard J. Buckley4 shared
- Matthew William Geoffrey Dye4 shared
- Michael C Keefer4 shared
- Sarah Elizabeth Peyre3 shared
- Robert C Rose3 shared
- Tracey L Baas2 shared
- John J Foxe2 shared
Most similar at University Of Rochester
Same institution · by research overlap
- Mark E. Dumont$10,787,618
- Robert C Rose$2,700,195
Others in their field
Top investigators on “Innovation”
- David R. Weir · University Of Michigan At Ann Arbor$382,307,654
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$319,874,172
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$311,654,401
- Richard A Gibbs · Baylor College Of Medicine$300,634,418
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$271,752,220
Research focus
InnovationUniversitiesTrainingProgramsAids/Hiv ProblemResearch PersonnelMentorsServicesResourcesMemberEnsureAcquired Immunodeficiency SyndromeFacultyInstructionCollaborationsStructureBiologyCommunitiesAreaGrantEvaluationTranslational ResearchTechnologyNext Generation
Grant awards (143)
University of Rochester HIV/AIDS Clinical Trials Unit$1,831,085
UM1 · FY2024 · AI
IRACDA at Rochester Partnership to Advance Research and Academic Careers in Deaf Scholars$1
K12 · FY2024 · GM · contact PI
University of Rochester HIV/AIDS Clinical Trials Unit$1,757,954
UM1 · FY2023 · AI
IRACDA at Rochester Partnership to Advance Research and Academic Careers in Deaf Scholars$1,145,594
K12 · FY2023 · GM · contact PI
University of Rochester HIV/AIDS Clinical Trials Unit$1,892,537
UM1 · FY2022 · AI
COV-IDD: Testing for COVID-19 in high risk children with intellectual and developmental disabilities$1,332,913
OT2 · FY2022 · HD
IRACDA at Rochester Partnership to Advance Research and Academic Careers in Deaf Scholars$1,145,594
K12 · FY2022 · GM · contact PI
COV-IDD: Testing for COVID-19 in high risk children with intellectual and developmental disabilities$2,667,087
OT2 · FY2021 · HD
University of Rochester HIV/AIDS Clinical Trials Unit$1,762,495
UM1 · FY2021 · AI
IRACDA at Rochester Partnership to Advance Research and Academic Careers in Deaf Scholars$1,147,594
K12 · FY2021 · GM · contact PI
Rochester Partnership to Advance Research and Academic Careers in Deaf Scholars$480,754
K12 · FY2020 · GM · contact PI
Rochester Partnership to Advance Research and Academic Careers in Deaf Scholars$951,669
K12 · FY2019 · GM · contact PI
Infection and Immunity: The Pathogenesis of Host-Microbe Interactions$240,883
T32 · FY2019 · AI · contact PI
Rochester Partnership to Advance Research and Academic Careers in Deaf Scholars$952,188
K12 · FY2018 · GM · contact PI
University of Rochester Center for AIDS Research$772,427
P30 · FY2018 · AI · contact PI
URBEST: The University of Rochester BEST Training Program$355,661
DP7 · FY2018 · OD · contact PI
Developmental Core$270,390
P30 · FY2018 · AI · contact PI
Infection and Immunity: The Pathogenesis of Host-Microbe Interactions$239,430
T32 · FY2018 · AI · contact PI
Administrative Core$230,159
P30 · FY2018 · AI · contact PI
Clinical and Translational Sciences Core$116,846
P30 · FY2018 · AI · contact PI
Biostatistics, Bioinformatics & Computational Biology Core$113,637
P30 · FY2018 · AI · contact PI
Basic Sciences Core$41,395
P30 · FY2018 · AI · contact PI
University of Rochester Center for AIDS Research$1,544,856
P30 · FY2017 · AI · contact PI
Developmental Core$462,701
P30 · FY2017 · AI · contact PI
Biostatistics, Bioinformatics & Computational Biology Core$416,915
P30 · FY2017 · AI · contact PI
Administrative Core$379,292
P30 · FY2017 · AI · contact PI
URBEST: The University of Rochester BEST Training Program$355,661
DP7 · FY2017 · OD · contact PI
Infection and Immunity: The Pathogenesis of Host-Microbe Interactions$232,387
T32 · FY2017 · AI · contact PI
Clinical and Translational Sciences Core$173,268
P30 · FY2017 · AI · contact PI
Basic Sciences Core$112,680
P30 · FY2017 · AI · contact PI
University of Rochester Center for AIDS Research$2,014,115
P30 · FY2016 · AI · contact PI
Rochester Partnership to Advance Research and Academic Careers in Deaf Scholars$685,978
K12 · FY2016 · GM · contact PI
Developmental Core$657,971
P30 · FY2016 · AI · contact PI
Administrative Core$575,703
P30 · FY2016 · AI · contact PI
Biostatistics, Bioinformatics & Computational Biology Core$405,783
P30 · FY2016 · AI · contact PI
URBEST: The University of Rochester BEST Training Program$366,183
DP7 · FY2016 · OD · contact PI
Infection and Immunity: The Pathogenesis of Host-Microbe Interactions$234,310
T32 · FY2016 · AI · contact PI
Basic Sciences Core$205,305
P30 · FY2016 · AI · contact PI
Clinical and Translational Sciences Core$169,353
P30 · FY2016 · AI · contact PI
University of Rochester Center for AIDS Research$1,696,203
P30 · FY2015 · AI · contact PI
Developmental Core$594,434
P30 · FY2015 · AI · contact PI
Rochester Partnership to Advance Research and Academic Careers in Deaf Scholars$431,338
K12 · FY2015 · GM · contact PI
The Semen Enhancer of HIV Infection as a Novel Microbicide Target$368,461
R33 · FY2015 · AI · contact PI
URBEST: The University of Rochester BEST Training Program$366,183
DP7 · FY2015 · OD · contact PI
Biostatistics, Bioinformatics & Computational Biology Core$347,671
P30 · FY2015 · AI · contact PI
Administrative Core$298,410
P30 · FY2015 · AI · contact PI
Basic Sciences Core$287,510
P30 · FY2015 · AI · contact PI
Enhanced Live Attenuated Influenza Virus With Improved Safety and Immunogenicity$248,425
R21 · FY2015 · AI · contact PI
Infection and Immunity: The Pathogenesis of Host-Microbe Interactions$231,848
T32 · FY2015 · AI · contact PI
Clinical and Translational Sciences Core$168,178
P30 · FY2015 · AI · contact PI
University of Rochester Center for AIDS Research$1,704,130
P30 · FY2014 · AI · contact PI
Developmental Core$618,448
P30 · FY2014 · AI · contact PI
Inhibition of HIV-Induced Synaptodentritic Damage$607,680
R44 · FY2014 · MH
URBEST: The University of Rochester BEST Training Program$366,183
DP7 · FY2014 · OD · contact PI
The Semen Enhancer of HIV Infection as a Novel Microbicide Target$365,454
R33 · FY2014 · AI · contact PI
Biostatistics, Bioinformatics & Computational Biology Core$347,670
P30 · FY2014 · AI · contact PI
Administrative Core$342,772
P30 · FY2014 · AI · contact PI
Basic Sciences Core$234,863
P30 · FY2014 · AI · contact PI
Enhanced Live Attenuated Influenza Virus With Improved Safety and Immunogenicity$191,875
R21 · FY2014 · AI · contact PI
Clinical and Translational Sciences Core$160,377
P30 · FY2014 · AI · contact PI
University of Rochester Center for AIDS Research$1,726,490
P30 · FY2013 · AI · contact PI
Inhibition of HIV-Induced Synaptodentritic Damage$566,811
R44 · FY2013 · MH
Administrative Core$552,902
P30 · FY2013 · AI · contact PI
The Semen Enhancer of HIV Infection as a Novel Microbicide Target$367,678
R33 · FY2013 · AI · contact PI
Developmental Core$352,800
P30 · FY2013 · AI · contact PI
Biostatistics, Bioinformatics & Computational Biology Core$327,724
P30 · FY2013 · AI · contact PI
Basic Sciences Core$252,902
P30 · FY2013 · AI · contact PI
Clinical and Translational Sciences Core$240,162
P30 · FY2013 · AI · contact PI
University of Rochester Developmental Center for AIDS Research$1,114,594
P30 · FY2012 · AI · contact PI
Developmental Core$415,612
P30 · FY2012 · AI · contact PI
Cerebrovascular mechanisms in methamphetamine-mediated exacerbation of neuroAIDS$373,275
R01 · FY2012 · DA · contact PI
The Semen Enhancer of HIV Infection as a Novel Microbicide Target$229,574
R21 · FY2012 · AI · contact PI
Administrative Core$201,003
P30 · FY2012 · AI · contact PI
University of Rochester Developmental Center for AIDS Research$1,456,878
P30 · FY2011 · AI · contact PI
Administrative Core$445,252
P30 · FY2011 · AI · contact PI
Developmental Core$406,922
P30 · FY2011 · AI · contact PI
Cerebrovascular mechanisms in methamphetamine-mediated exacerbation of neuroAIDS$373,245
R01 · FY2011 · DA · contact PI
Use of Discontinuous Peptide Display for Generation of HIV Antigen Mimics$228,690
R21 · FY2011 · AI · contact PI
The Semen Enhancer of HIV Infection as a Novel Microbicide Target$204,459
R21 · FY2011 · AI · contact PI
Cerebrovascular mechanisms in methamphetamine-mediated exacerbation of neuroAIDS$8,824
R01 · FY2011 · DA · contact PI
University of Rochester Developmental Center for AIDS Research$742,313
P30 · FY2010 · AI · contact PI
Transmission-blocking vaccine for HIV-1$450,307
R01 · FY2010 · AI · contact PI
Cerebrovascular mechanisms in methamphetamine-mediated exacerbation of neuroAIDS$343,035
R01 · FY2010 · DA · contact PI
Administrative Core$226,866
P30 · FY2010 · AI · contact PI
Developmental Core$207,336
P30 · FY2010 · AI · contact PI
Use of Discontinuous Peptide Display for Generation of HIV Antigen Mimics$191,666
R21 · FY2010 · AI · contact PI
Training in HIV Replication and Pathogenesis$152,566
T32 · FY2010 · AI · contact PI
Transmission-blocking vaccine for HIV-1$151,079
R01 · FY2010 · AI · contact PI
Cerebrovascular mechanisms in methamphetamine-mediated exacerbation of neuroAIDS$31,054
R01 · FY2010 · DA · contact PI
University of Rochester Developmental Center for AIDS Research$1,000,339
P30 · FY2009 · AI · contact PI
Transmission-blocking vaccine for HIV-1$466,471
R01 · FY2009 · AI · contact PI
Cerebrovascular mechanisms in methamphetamine-mediated exacerbation of neuroAIDS$346,500
R01 · FY2009 · DA · contact PI
Administrative Core$305,725
P30 · FY2009 · AI · contact PI
Developmental Core$279,406
P30 · FY2009 · AI · contact PI
Radioprotection by targeted siRNA delivery to salivary gland$231,000
R21 · FY2009 · DE
Training in HIV Replication and Pathogenesis$182,202
T32 · FY2009 · AI · contact PI
Lambda phage as a scaffold for influenza immunization$31,556
R21 · FY2009 · AI · contact PI
University of Rochester Developmental Center for AIDS Research$780,575
P30 · FY2008 · AI · contact PI
Cerebrovascular mechanisms in methamphetamine-mediated exacerbation of neuroAIDS$259,875
R01 · FY2008 · DA · contact PI
Lambda phage as a scaffold for influenza immunization$226,611
R21 · FY2008 · AI · contact PI
Overcoming Low HIV-1 Envelope Spike Immunogenicity By High Density Display$225,801
R21 · FY2008 · AI · contact PI
Administrative Core$217,470
P30 · FY2008 · AI · contact PI
Developmental Core$197,743
P30 · FY2008 · AI · contact PI
Radioprotection by targeted siRNA delivery to salivary gland$192,500
R21 · FY2008 · DE
Training in HIV Replication and Pathogenesis$113,547
T32 · FY2008 · AI · contact PI
Lambda phage as a scaffold for influenza immunization$192,500
R21 · FY2007 · AI · contact PI
Overcoming Low HIV-1 Envelope Spike Immunogenicity By High Density Display$191,773
R21 · FY2007 · AI · contact PI
Training in HIV Replication and Pathogenesis$180,778
T32 · FY2007 · AI · contact PI
Research and Education in Microbiology and Immunology$242,855
R25 · FY2006 · GM · contact PI
Bacteriophage gene transfer for HIV vaccine delivery$228,501
R21 · FY2006 · AI · contact PI
Training in HIV Replication and Pathogenesis$174,815
T32 · FY2006 · AI · contact PI
Research and Education in Microbiology and Immunology$369,487
R25 · FY2005 · GM
Adaptations of Human Herpesvirus-7 to Salivary Glands$355,669
R01 · FY2005 · DE
Bacteriophage gene transfer for HIV vaccine delivery$234,000
R21 · FY2005 · AI
Training in HIV Replication and Pathogenesis$169,156
T32 · FY2005 · AI
LENTIVIRUS ATTENUATION THROUGH HIGH FIDELITY REPLICATION$376,513
P51 · FY2004 · RR
Research and Education in Microbiology and Immunology$358,725
R25 · FY2004 · GM
Adaptations of Human Herpesvirus-7 to Salivary Glands$354,135
R01 · FY2004 · DE
Training in HIV Replication and Pathogenesis$169,156
T32 · FY2004 · AI
Research and Education in Microbiology and Immunology$348,277
R25 · FY2003 · GM
Adaptations of Human Herpesvirus-7 to Salivary Glands$303,050
R01 · FY2003 · DE
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW$300,000
U09 · FY2003 · AI
DISREGULATION OF NEURONAL GSK-3BETA BY PAF$279,125
R01 · FY2003 · NS
Training in HIV Replication and Pathogenesis$165,596
T32 · FY2003 · AI
Adaptations of Human Herpesvirus-7 to Salivary Glands$49,597
R01 · FY2003 · DE
Adaptations of Human Herpesvirus-7 to Salivary Glands$303,050
R01 · FY2002 · DE
DISREGULATION OF NEURONAL GSK-3BETA BY PAF$279,125
R01 · FY2002 · NS
Research and Education in Microbiology and Immunology$277,113
R25 · FY2002 · GM
Role of GSK-3beta in HIV 1 induced neuronal damage$266,631
P01 · FY2002 · MH
Role of GSK-3beta in HIV 1 induced neuronal damage$266,631
P01 · FY2002 · MH
LENTIVIRUS ATTENUATION THROUGH HIGH FIDELITY REPLICATION$238,070
R21 · FY2002 · AI
Training in HIV Replication and Pathogenesis$157,682
T32 · FY2002 · AI
Adaptations of Human Herpesvirus-7 to Salivary Glands$48,153
R01 · FY2002 · DE
Adaptations of Human Herpesvirus-7 to Salivary Glands$303,050
R01 · FY2001 · DE
DISREGULATION OF NEURONAL GSK-3BETA BY PAF$279,125
R01 · FY2001 · NS
LENTIVIRUS ATTENUATION THROUGH HIGH FIDELITY REPLICATION$252,945
R21 · FY2001 · AI
NOVEL SYSTEMS FOR CNS GENE THERAPY$159,299
R21 · FY2001 · DK
Training in HIV Replication and Pathogenesis$158,088
T32 · FY2001 · AI
Role of GSK-3beta in HIV 1 induced neuronal damage$0
P01 · FY2001 · MH
NFKB AND OXIDATIVE STRESS IN NEURO-AIDS$382,503
P01 · FY2000 · MH
DISREGULATION OF NEURONAL GSK-3BETA BY PAF$279,125
R01 · FY2000 · NS
CYTOMEGALOVIRUS VECTORS FOR HIV VACCINE DEVELOPMENT$239,250
R21 · FY2000 · AI
NOVEL SYSTEMS FOR CNS GENE THERAPY$158,956
R21 · FY2000 · DK